技术与方法 |
|
|
|
|
HPLC法测定重组人干扰素α1b粉雾剂的含量 |
刘阿娜1,2,周敏毅2**,宋文进2,刘建平1 |
1.中国药科大学药学院 南京 210009
2.北京三元基因工程有限公司 北京 102600 |
|
Determination of Content of Recombinant Human Interferon α1b Dry Powder Inhalation by HPLC |
LIU A-na1,2,ZHOU Min-yi2,SONG Wen-jin2,LIU Jian-ping1 |
1.School of Pharmacy,China Pharmaceutical University,Nanjing 210009,China
2.Beijing Tri-Prime Genetic Engineering Co.Ltd.,Beijing 102600,China |
[1] 侯云德.分子病毒学.北京:学苑出版社,1990,598599. Hou Y D.Molecular Virology.Beijing: Academy Press,1990,598599.
[2] 中国药典(三部).北京:中国医药科技出版社,2010,附录ⅩC. ChP(Vol Ⅲ) .Beijing:China Medical Science and Technology Press,2010,Appendix ⅩC.
[3] HakKim C,Andy C,Igor G,et al .Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery.pharmaceutical research,1997 ,4(14):431437.
[4] Hiroaki T,Hirokazu O,Kotaro I,et al.Improvement of stability and absorbability of dry insulin powder for inhalation by powderconbination technique.International Journal of Pharmaceutics,2004,3(271):4152.
[5] YuhFun M,PhuongAnh N,Theresa S,et al.Protein inhalation powders: spray drying vs spray freeze drying.Pharmaceutical Research,1999,2(16):249254.
[6] 那伊.蛋白质药物开发与生产.北京:化学工业出版社,2006,28. Na Y.Protein DrugsDevelopment and Production.Beijing: Chemical Industry Press,2006,28.
[7] 吴美英,曹艳,孙俭波.应用高效液相色谱法定量检测重组人干扰素alb.中国生物制品学杂,2003,16(3):175176. Wu M Y,Cao Y,Sun J B.Chinese Journal of Biologicals,2003,16(3):175176.
[8] 陈勇,陈妍.重组干扰素α1b壳聚糖涂膜剂的制备及质量控制.中国药房,2006,17(1):2728. Chen Y,Chen Y.China Pharmacy,2006,17(1):2728.
[9] 中国药典(二部).北京:中国医药科技出版社,2010,附录ⅠL. ChP(Vol Ⅱ) .Beijing:China Medical Science and Technology Press,2010,Appendix ⅠL.
[10] 国家食品药品监督管理局吸入制剂质量控制研究技术指导原则2007,124. SFDA. Guidance on the quality control of inhalation products2007,124. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|